NeoGenomics, Inc.
corporate_fare Company Profile
NeoGenomics, Inc. (NASDAQ:NEO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for NEO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- NeoGenomics Reports Full-Year 2025 Results with Increased Loss, Significant Impairments, and Key Patent Litigation Win
- NeoGenomics Reports Strong 2025 Revenue Growth, Positive 2026 Guidance, and Strategic Product Launch
- NeoGenomics Reports Strong Preliminary Q4 & FY25 Revenue, Announces CFO Transition
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$727.33M
Net Income
-$108.03M
Op. Cash Flow
$5.23M
Free Cash Flow
-$21.78M
Gross Profit
$314.29M
Operating Income
-$115.88M
Cash & Equivalents
$159.62M
Total Debt
$341.86M
Debt / Equity
0.41×
Net Margin
-14.9%
Shares Outstanding
128.15M sh
Source: 10-K · filed 2026-02-17 · accession 0001077183-26-000010
show_chartPrice Chart
Loading chart...
feed NEO - Filings & News (Page 2)
NEO
Feb 17, 2026, 4:17 PM EST
Price at Filing:
$11.35
Real-time Price:
$14.79
Change:
+$3.44 (+30%)
Market Cap:
$1.918B
NEO
Feb 17, 2026, 7:06 AM EST
NeoGenomics Reports Strong 2025 Revenue Growth, Positive 2026 Guidance, and Strategic Product Launch
Price at Filing:
$11.20
Real-time Price:
$14.79
Change:
+$3.59 (+32%)
Market Cap:
$1.918B
NEO
Jan 12, 2026, 7:10 AM EST
Price at Filing:
$13.25
Real-time Price:
$14.79
Change:
+$1.54 (+12%)
Market Cap:
$1.918B